FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
The deadline for health delivery organizations to apply for the AHA’s 2026 Foster G. McGaw Prize is 1 p.m. ET May 6. The award honors organizations that…
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban…
Headline
Cigarette smoking by adults has dropped to its lowest level in 60 years, the Centers for Disease Control and Prevention reported today. Despite that, tobacco…
Headline
In this conversation, Mindy Estes, M.D., former CEO of Saint Luke's Health System and former AHA board chair, and Roxanna Gapstur, R.N., CEO of WellSpan Health…
Headline
A case study by the AHA's Community Health Improvement network explains how Children’s Mercy Kansas City created a new model to coordinate its community…
Chairperson's File
Trust — in one another, in our field, and in our communities — is so important to what we do. Everyone should know that our hospitals and health systems are a…